2019 Diabetes Management Medical 
Family Medicine Initiative
APRIL 9, 2024
Demand for new obesity medications like semaglutide (GLP-1 analogs) is high, but availability is low. Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? mg or placebo in 2019. So, which patients should get them first? semaglutide 1.0
Annals of Family Medicine
NOVEMBER 20, 2024
Health insurance instability may be particularly challenging for patients with diabetes who need regular chronic care management to reduce the risk of diabetes complications. 46,844 patients were diagnosed with diabetes during study period. Having a prescription of insulin was not associated with likelihood of churning.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
JUNE 8, 2025
The commonest strategy to manage acute pain in preterm babies is to give them sucrose , a sugar solution. One of these sites does not use sucrose for acute pain management. We found no link between preterm babies later behavior and how much sucrose they were given to manage pain. Whats more, pain isnt always managed.
FDA Law Blog
FEBRUARY 9, 2022
DEA regulations state that a pharmacist has a corresponding responsibility not to fill a prescription unless it is issued for a “legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” 12, 2012) (quoting Bob’s Pharmacy & Diabetic Supplies; Revocation of Registration, 74 Fed.
FDA Law Blog
SEPTEMBER 8, 2022
As it stands, the rule allows insurers and pharmacy benefit managers (PBMs) to broadly use copay accumulator programs, which have long been criticized by patient advocacy groups as padding insurers’ pockets while leaving patients high and dry. These prohibitions are often referred to as copay accumulator adjustment programs.
Expert insights. Personalized for you.
130 
Let's personalize your content